{
    "organizations": [],
    "uuid": "95457ed483b5a197ea3c9dcee627227153f7435e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-mithra-pharmaceuticals-applies-for/brief-mithra-pharmaceuticals-applies-for-additional-estelle-patent-based-on-positive-hemostasis-data-idUSFWN1R90ZA",
    "ord_in_thread": 0,
    "title": "BRIEF-Mithra Pharmaceuticals Applies For Additional Estelle® Patent Based On Positive Hemostasis Data",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 28 (Reuters) - MITHRA PHARMACEUTICALS SA:\n* MITHRA APPLIES FOR ADDITIONAL ESTELLE® PATENT BASED ON POSITIVE HEMOSTASIS DATA\n* THE PATENT APPLICATION IS FOR EUROPE, CO PLANS TO MAKE FURTHER APPLICATIONS IN MORE REGIONS‍​\n* ‍PATENT WOULD EXTEND EXISTING INTELLECTUAL PROPERTY ESTATE​ OF ESTELLE COMPONENT ESTETROL Source text: bit.ly/2J0VMny Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-03-28T13:45:00.000+03:00",
    "crawled": "2018-03-29T15:26:19.008+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "mithra",
        "pharmaceutical",
        "sa",
        "mithra",
        "applies",
        "additional",
        "patent",
        "based",
        "positive",
        "hemostasis",
        "data",
        "patent",
        "application",
        "europe",
        "co",
        "plan",
        "make",
        "application",
        "would",
        "extend",
        "existing",
        "intellectual",
        "property",
        "estelle",
        "component",
        "estetrol",
        "source",
        "text",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}